MINNEAPOLIS, Minnesota—OneOme, LLC, a pharmacogenomics company, recently announced that it appointed Paul Owen as its Chief Operating Officer.
Troy Kopischke, CEO, stated: “Owen’s experience and expertise in pharmacogenomics are incredible assets for OneOme. His leadership will drive OneOme toward our goal of bringing pharmacogenomics to the point of care.”
“OneOme’s business model and vision is very compelling to me, and we have an opportunity to make a significant difference in the pharmacogenomics space. I am incredibly energized to help lead the company to its next phase of innovation,” stated Owen.
Previously Owen worked at a genetic information company, Invitae Corporation. There, Paul was responsible for developing and implementing their global commercialization team. Prior to Invitae he lead the global commercial team for Mayo Medical Laboratories for 10 years and has been instrumental in leading various other functions within fortune 100 medical device companies.
About OneOme, LLC
OneOme, LLC, is a company dedicated to provide accurate, solutions for pharmacogenomic interpretation with actionable clinical information to support healthcare professionals with prescription decisions and individualized treatment plans. OneOme prides itself in the quality and accuracy of the data included in its libraries.